Efficacy and Safety Study of F373280

• Status: Completed
• Trial end date: 2017-06-21

Summary

The purpose of this study is to assess the efficacy of F373280 on the maintenance of normal cardiac rhythm after direct electric cardioversion in patients with persistent atrial fibrillation and cardiac failure.

• Phase: Phase 2

Details

• Lead Sponsor: Pierre Fabre Medicament